Mucoactive drugs

Journal Title: Alergoprofil - Year 2010, Vol 6, Issue 1

Abstract

The production of mucus is the first-line defense against inhaled harmful agents damaging the airway epithelium. The process in which airway mucus together with microbes, viruses and other particles trapped within is moved out of the respiratory tract, is termed mucociliary clearance. The effective ciliary movement and biophysical properties of mucus, especially its two features; viscosity and elasticity, affect on efficiency of this process. Under normal conditions airway mucus protects the lower respiratory tract against inhaled irritants. On the other hand, excessive production of airway mucus in respiratory diseases, such as chronic obstructive pulmonary disease, asthma or cystic fibrosis, is associated with number of complications. Mucus hypersecretion, related with changes in its biophysical properties, can weaken mucociliary clearance as well as favour accumulation of mucus in upper and lower airways. Mucoactive drugs, stimulating airway clearance, are one of the therapeutic options in these cases. According to the putative mechanism of action, these compounds are categorized to four main groups, as expectorants (induce cough), mucolytics (increase mucus viscosity), mucokinetics (facilitate ciliary movement) and mucoregulators (act on hypersecretion). It is noteworthy, that many of them have other beneficial effects besides influence on mucus and mucociliary clearance. For example, the experimental and clinical studies on erdosteine indicate its antioxidant, anti-inflammatory, antibacterial and mucolytic pharmacological activities. Although over 50 compounds have potentially profitable effect on airway mucus, the mechanism of action of numerous of it is imprecisely characterized or absolutely unknown. The accessible data does not interchangeably confirm benefits from use of mucoactive drugs, that is why the further studies on efficacy of its action should be carrying out.

Authors and Affiliations

Anna Zasowska-Nowak, Dariusz Nowak

Keywords

Related Articles

Populus pollen in the air of selected Polish cities in 2009

This paper presents the course of poplar pollination season in selected cites of Poland in 2009.The measurements were performed in Białystok, Bydgoszcz, Łódź, Olsztyn, Szczecin, Warsaw, Wrocław and Zielona Góra. The res...

Ash pollen in the air of selected Polish cities in 2008

The aim of the study was to compare the pollen season of ash in the cities of Szczecin, Warsaw, Krakow, Lublin, Sosnowiec, Białystok and Bydgoszcz in 2008. Measurements were performed by the volumetric method (Burkard an...

Analiza stężenia pyłku bylicy w wybranych miastach Polski w roku 2007

Praca przedstawia przebieg sezonu pylenia bylicy w wybranych punktach pomiarowych w Polsce w 2007 r. Badania przeprowadzono w Białymstoku, Bydgoszczy, Krakowie, Lublinie, Łodzi, Olsztynie, Szczecinie, Warszawie i we Wroc...

Diagnosis of drug allergy. Management of patients with a history of beta-laktam antibiotic and local anesthesis allergy

The author presents the most important issues considering drug allergies. Diagnostic procedures with specific recommendations for patients with beta-lactam antibiotics and local anesthetics allergy are discussed.

Rodzaj Torula jako źródło potencjalnych alergenów grzybowych

Na rodzaj Torula składa się sześć wszechobecnych, kosmopolitycznych gatunków, które mogą wywoływać objawy kataru siennego i astmy. Obecność spor tego rodzaju stwierdzono w atmosferze Stanów Zjednoczonych, Wenezueli, Chil...

Download PDF file
  • EP ID EP97191
  • DOI -
  • Views 79
  • Downloads 0

How To Cite

Anna Zasowska-Nowak, Dariusz Nowak (2010). Mucoactive drugs. Alergoprofil, 6(1), 7-13. https://europub.co.uk/articles/-A-97191